Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Aplenc

Showing results (121-130 of 254) with videos related to

Pageof 26
Sort By:
Pediatric Blood & Cancer|September 30, 2023
Acute and chronic kidney injury during therapy for pediatric acute leukemia: A report from the Leukemia Electronic Abstraction of Records Network (LEARN)Wendy Hsiao, Yimei Li, Kelly Getz, et al.
Bone Marrow Transplantation|January 7, 2022
Adolescent and young adult (AYA) versus pediatric patients with acute leukemia have a significantly increased risk of acute GVHD following unrelated donor (URD) stem cell transplantation (SCT): the Children's Oncology Group experienceJeffrey R Andolina, Yi-Cheng Wang, Lingyun Ji, et al.
Leukemia & Lymphoma|November 21, 2012
Variation in hospital antibiotic prescribing practices for children with acute lymphoblastic leukemiaBrian T Fisher, Jeffrey S Gerber, Kateri H Leckerman, et al.
Cancer|February 26, 2013
Induction mortality and resource utilization in children treated for acute myeloid leukemia at free-standing pediatric hospitals in the United StatesMarko Kavcic, Brian T Fisher, Yimei Li, et al.
Leukemia & Lymphoma|May 21, 2020
Safety of gemtuzumab ozogamicin as monotherapy or combination therapy in an expanded-access protocol for patients with relapsed or refractory acute myeloid leukemiaEunice S Wang, Richard Aplenc, Deborah Chirnomas, et al.
Cancer Medicine|July 31, 2016
Early discharge as a mediator of greater ICU-level care requirements in patients not enrolled on the AAML0531 clinical trial: a Children's Oncology Group reportKelly D Getz, Tamara P Miller, Alix E Seif, et al.
Pediatric Blood & Cancer|December 30, 2017
Identifying patient- and family-centered outcomes relevant to inpatient versus at-home management of neutropenia in children with acute myeloid leukemiaJulia E Szymczak, Kelly D Getz, Rachel Madding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2021
CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology GroupAdam J Lamble, Lisa Eidenschink Brodersen, Todd A Alonzo, et al.
Pediatric Dermatology|July 6, 2019
Pediatric leukemia cutis: A case seriesElena Corina Andriescu, Carrie C Coughlin, Carol E Cheng, et al.
Pediatric Blood & Cancer|November 23, 2021
Incidence and risk factors for hypoglycemia during maintenance chemotherapy in pediatric acute lymphoblastic leukemiaElizabeth Rosenfeld, Kelly D Getz, Tamara P Miller, et al.
Pageof 26

Showing results (121-130 of 254) with videos related to

Sort By:
Pageof 26
Pediatric Blood & Cancer|September 30, 2023
Acute and chronic kidney injury during therapy for pediatric acute leukemia: A report from the Leukemia Electronic Abstraction of Records Network (LEARN)Wendy Hsiao, Yimei Li, Kelly Getz, et al.
Bone Marrow Transplantation|January 7, 2022
Adolescent and young adult (AYA) versus pediatric patients with acute leukemia have a significantly increased risk of acute GVHD following unrelated donor (URD) stem cell transplantation (SCT): the Children's Oncology Group experienceJeffrey R Andolina, Yi-Cheng Wang, Lingyun Ji, et al.
Leukemia & Lymphoma|November 21, 2012
Variation in hospital antibiotic prescribing practices for children with acute lymphoblastic leukemiaBrian T Fisher, Jeffrey S Gerber, Kateri H Leckerman, et al.
Cancer|February 26, 2013
Induction mortality and resource utilization in children treated for acute myeloid leukemia at free-standing pediatric hospitals in the United StatesMarko Kavcic, Brian T Fisher, Yimei Li, et al.
Leukemia & Lymphoma|May 21, 2020
Safety of gemtuzumab ozogamicin as monotherapy or combination therapy in an expanded-access protocol for patients with relapsed or refractory acute myeloid leukemiaEunice S Wang, Richard Aplenc, Deborah Chirnomas, et al.
Cancer Medicine|July 31, 2016
Early discharge as a mediator of greater ICU-level care requirements in patients not enrolled on the AAML0531 clinical trial: a Children's Oncology Group reportKelly D Getz, Tamara P Miller, Alix E Seif, et al.
Pediatric Blood & Cancer|December 30, 2017
Identifying patient- and family-centered outcomes relevant to inpatient versus at-home management of neutropenia in children with acute myeloid leukemiaJulia E Szymczak, Kelly D Getz, Rachel Madding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2021
CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology GroupAdam J Lamble, Lisa Eidenschink Brodersen, Todd A Alonzo, et al.
Pediatric Dermatology|July 6, 2019
Pediatric leukemia cutis: A case seriesElena Corina Andriescu, Carrie C Coughlin, Carol E Cheng, et al.
Pediatric Blood & Cancer|November 23, 2021
Incidence and risk factors for hypoglycemia during maintenance chemotherapy in pediatric acute lymphoblastic leukemiaElizabeth Rosenfeld, Kelly D Getz, Tamara P Miller, et al.
Pageof 26